|
Prepared by: Dante Fichera, CPA
This reporting period companies based in New Jersey operating in the Communications industry and that have raised their Later round of financing led the pack in the amount of venture financing raised. Also, there was eight IPOs this reporting period.
|
 |
CapitalHunter.com was able to verify that $589 million of venture capital was invested in 33 U.S.-based companies during this week’s reporting period. The average deal size was approximately $20.31 million. The amount of venture capital invested this period increased by 147% compared to last periods $238 million. |
|
|
 |
Geographically, 5 New Jersey companies raised $262.5 million in venture financings which represents 44% of the total venture capital invested this reporting period. The largest private venture financing in New Jersey this period was into Vonage Corporation. Vonage Corporation raised $200 million and is a Edison based communications company and is provider of high-speed Internet-based digital telephone services. |
|
|
 |
The Communications sector raised 34% of the venture capital this period. one communication company raised $200 million in venture financing. The largest private venture financing in the Communcations sector this period was into Vonage. |
|
|
 |
|
Companies raising their Later round of financing led this week’s venture capital activity. Later financings represented 41% of the total venture capital deployed this period. The largest private venture financing in Later stage financing this period was into Vonage.
|
|
|
 |
|
The three largest venture deals this period are as follows: |
| |
Company |
Industry |
Investment |
| 1 |
Vonage |
Communications |
$200 million |
| 2 |
Celator Pharmaceuticals |
Biotechnology |
$40 million |
| 3 |
Bayhill Therapeutics |
Biotechnology |
$35.4 million |
|
 |
|
The following twenty five and other unnamed investors funded the above mentioned top three venture capital investments for $275.4 Million: |
| 1 | 3i Group | | 2 | A M Pappas and Associates | | 3 | Bain Capital Ventures | | 4 | Boston Life Science Venture | | 5 | Business Development Bank of Canada | | 6 | CMEA Ventures | | 7 | De Novo Ventures | | 8 | Domain Associates | | 9 | Grand Cathay Venture Capital Company | | 10 | GrowthWorks Capital | | 11 | Institution Venture Partners | | 12 | Latterell Venture Partners | | 13 | Lilly Ventures | | 14 | Meritech Capital Partners | | 15 | Montreux Equity Partners | | 16 | Morgenthaler Venture | | 17 | New Enterprise Associates | | 18 | PAC-LINK Bio Management | | 19 | Prudence Venture Investment | | 20 | Quaker BioVentures | | 21 | Quintiles PharmaBio Development | | 22 | TL Ventures | | 23 | U S Venture Partners | | 24 | Ventures West | | 25 | Vertical Group |
|
A total of 71 equity financings of private and public companies occurred during this reporting period. Each of the 71 equity financings are profiled in a weekly report which include venture financings, private placements, secondary offerings, PIPE’s, and IPO’s.
About CapitalHunter.com
CapitalHunter.com is a web-based financial information company that identifies, preserves and electronically disseminates worldwide data on venture capital and other equity financings. Customers utilize the CapitalHunter.com searchable database to research newly and historic financings and to identify active investors.
Please visit www.capitalhunter.com and get immediate access. New subscribers can request a free investor analysis. |
|
|
|
©2003 Capital Hunter, Inc. all rights reserved
|
To be REMOVED from this free service, CLICK HERE |
